SCHEMBL27211503

SCHEMBL27211503

CCOC(=O)c1cc(C(=O)c2ccc(OC)cc2)n2ccc(N)cc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCHE P06276 1/20 0.52
▸ ACHE P22303 1/20 0.52
▸ ALDH1A1 P00352 2/20 0.50
▸ FNTA P49354 9/20 0.49
▸ FNTB P49356 9/20 0.49
▸ MAPT P10636 3/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ GAA P10253 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ CASP3 P42574 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ SENP8 Q96LD8 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ SENP7 Q9BQF6 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27211444 0.88 ALDH1A1 (0.51) BCHEACHEALDH1A1FNTAFNTB
SCHEMBL27211499 0.88 FNTA (0.52) ALDH1A1FNTAFNTBMAPTGAA
SCHEMBL27211517 0.88 FNTA (0.52) BCHEACHEALDH1A1FNTAFNTB
SCHEMBL27211468 0.75 ALDH1A1 (0.47) ALDH1A1FNTAFNTBMAPTKMT2A
SCHEMBL24748998 0.75 KLF10 (0.41) BCHEACHEALDH1A1FNTAFNTB
SCHEMBL29766498 0.74 ALDH1A1 (0.56) ACHEALDH1A1FNTAFNTBMEN1
SCHEMBL26830001 0.73 ALDH1A1 (0.54) BCHEACHEALDH1A1FNTAFNTB
SCHEMBL26413682 0.72 FNTA (0.59) ALDH1A1FNTAFNTBGAAKDM4E
SCHEMBL26131444 0.72 FNTA (0.62) ALDH1A1FNTAFNTBMEN1KMT2A
SCHEMBL26829994 0.72 ALDH1A1 (0.52) BCHEACHEALDH1A1FNTAFNTB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11976066-B1 Substituted 7-amino-3-(substituted benzoyl)indolizine-1-carboxylates as anti-tubercular agents King Faisal University (SA) 2024-05-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11976066-B1 Substituted 7-amino-3-(substituted benzoyl)indolizine-1-carboxylates as anti-tubercular agents BET1, INMT, IDO1 BCHE 806/4885ACHE 1939/4885ALDH1A1 612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback